 | | | | (Reuters) - The U.S. Food and Drug Administration on Tuesday sent warning letters to nine online networks operating a total of 53 websites to stop illegally marketing unapproved versions of opioid medications. | | |
| | | (Reuters) - Scientists seeking new ways to fight drug-resistant superbugs have mapped the genomes of more than 3,000 bacteria, including samples of a bug taken from Alexander Fleming's nose and a dysentery-causing strain from a World War One soldier. | | |
| | | NEW YORK (Reuters) - A recently adopted tactic by U.S. health plans to limit the financial assistance drugmakers provide directly to consumers for prescription medicines is taking a toll on drug prices, according to a new analysis released on Tuesday. | | |
| | | NEW YORK (Reuters) - The U.S. government's healthcare program for the elderly will exhaust its reserves for hospital insurance in 2026, three years earlier than last year's forecast, the Social Security and Medicare Boards of Trustees said in a report on Tuesday. | | |
| | | (Reuters Health) - Prostate cancer patients who smoke are more likely to have tumors return, spread to other parts of the body, and become fatal than nonsmokers, a new study suggests. | | |
| | | (Reuters Health) - Murder, suicide, car crashes, and addiction have all contributed to a spike in deaths among U.S. children and teens in recent years, a government study suggests. | | |
| | | (Reuters Health) - Women who have an abortion may be no more likely to develop depression than women who don't, a Danish study suggests. | | |
| | | (Reuters Health) - Falls, car crashes and other accidents off the battlefield cause one-third of injuries and about one in 10 deaths among U.S. service members deployed to Iraq and Afghanistan, a U.S. study suggests. | | |
| | | WASHINGTON (Reuters) - The U.S. Supreme Court on Monday threw out a lower court ruling that let a pregnant illegal immigrant minor held in federal immigration custody obtain an abortion last year at age 17 over the objections of President Donald Trump's administration. | | |
| | | (Reuters) - Abbvie Inc said on Tuesday its experimental drug met the main goal of halting progression of moderate-to-severe rheumatoid arthritis in a late-stage trial. | | |
|
| |
